National Human Genome Research Institute; Notice of Meeting, 48747-48748 [2021-18726]
Download as PDF
<![CDATA[
48747
Federal Register / Vol. 86, No. 166 / Tuesday, August 31, 2021 / Notices
5267 or Email your request, including
your address to: marla.jacobson@
nih.gov. Formal requests for additional
plans and instruments must be
requested in writing.
SUPPLEMENTARY INFORMATION: This
proposed information collection was
previously published in the Federal
Register on May 19, 2021, page 27093
(Vol. 86 FR 27093) and allowed 60 days
for public comment. No public
comments were received. The National
Cancer Institute (NCI), National
Institutes of Health, may not conduct or
sponsor, and the respondent is not
required to respond to, an information
collection that has been extended,
revised, or implemented on or after
October 1, 1995, unless it displays a
currently valid OMB control number.
In compliance with Section
3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH) has submitted
to the Office of Management and Budget
(OMB) a request for review and
approval of the information collection
listed below.
Proposed Collection: Evaluation of
Office of Acquisitions System (OASYS)
email (future OASYS Vendor Portal
Users) and were (current FCAS Vendor
Portal Users) to individual OA
recipients. The FCAS Vendor Portal and
in the future, the OASYS Vendor Portal
will serve as a one-stop shop for
transmission of requests, reports,
deliverables and other correspondence
due on numerous research and
development, in support of R&D
contracts as well as those contract
vehicles awarded using various Federal
Acquisition Procedures including but
not limited to FAR Part 8, Required
Sources of Supplies and Services, FAR
Part 13, Simplified Acquisition
Procedures, and FAR Part 12,
Acquisition of Commercial Items. These
reports and deliverables cover a wide
variety of topics in the areas of cancer
research including prevention,
detection, diagnosis, and control.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
232.
and FFRDC Contract Administration
System (FCAS) Vendor Portals National
Cancer Institute (NCI), 0925–NEW,
Expiration Date XX/XX/XXXX, NEW,
National Cancer Institute (NCI),
National Institutes of Health (NIH).
Need and Use of Information
Collection: The National Cancer
Institute (NCI) Office of Acquisitions
(OA), located within the Office of the
Director (OD) in the Office of
Management (OM) at the National
Cancer Institute (NCI), awards and
administers contracts and simplified
acquisitions in support of the Institute’s
mission to prevent, diagnose and treat
cancer. During the acquisition process,
the OA ensures that customer service is
paramount, and communications are
open and continuous. Currently
requests and correspondence are sent to
and received from vendors through
email with the exception of the FFRDC
Contractor who submits through the
FCAS Vendor Portal which is in
production. To streamline processes,
increase transparency and gain
efficiencies, the OA developed OASYS
and FCAS vendor portals to replace
processes that are handled through
ESTIMATED ANNUALIZED BURDEN HOURS
Number of
responses per
respondent
Average time
per response
(in hours)
Total annual
burden hours
Type of respondent
Survey—OASYS ...............................
Survey—FCAS ..................................
Registration—OASYS .......................
Registration—FCAS ..........................
Data Field Information—OASYS ......
Data Field Information—FCAS .........
Add/Edit new Vendor User—OASYS
Add/Edit new Vendor User—FCAS ..
Individuals ........................................
Individuals ........................................
Corporations .....................................
Corporations .....................................
Individuals ........................................
Individuals ........................................
Corporations .....................................
Corporations .....................................
10
1
400
1
400
61
40
6
1
1
1
1
18
63
1
1
6/60
6/60
6/60
6/60
1/60
1/60
6/60
6/60
1
1
40
1
120
64
4
1
Totals .........................................
...........................................................
919
11,501
........................
232
Dated: August 26, 2021.
Vivian Horovitch-Kelley,
Project Clearance Liaison, National Cancer
Institute, National Institutes of Health.
Maryland, 20892, which was published
in the Federal Register on August 4,
2021, FR Doc 2021–16549, 86 FR 41983.
This notice is being amended to
change the start time for the second
Open session on September 1, 2021,
which will now be 12:30 p.m. and will
still end at 2:30 p.m. as listed. The
meeting is closed to the public.
[FR Doc. 2021–18767 Filed 8–30–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Dated: August 25, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
National Institutes of Health
khammond on DSKJM1Z7X2PROD with NOTICES
Number of
respondents
Form name
National Institute of Environmental
Health Sciences; Amended Notice of
Meeting
[FR Doc. 2021–18725 Filed 8–30–21; 8:45 am]
Notice is hereby given of a change in
the meeting of the National Heart, Lung,
and Blood Advisory Council, August 31,
2021–September 1, 2021, National
Institutes of Health, Bethesda,
VerDate Sep<11>2014
20:08 Aug 30, 2021
Jkt 253001
BILLING CODE 4140–01–P
PO 00000
Frm 00089
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Human Genome Research
Institute; Notice of Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Advisory
Council for Human Genome Research.
The meeting will be open to the
public as indicated below, the 94th
meeting of the National Advisory
Council for Human Genome Research
open session will be livestreamed and
available for viewing to the public from
https://www.genome.gov/eventcalendar/94th-Meeting-of-NationalAdvisory-Council-for-Human-Genome-
E:\FR\FM\31AUN1.SGM
31AUN1
48748
Federal Register / Vol. 86, No. 166 / Tuesday, August 31, 2021 / Notices
khammond on DSKJM1Z7X2PROD with NOTICES
Research. The open session will be on
September 13th and the start time will
be 10:00 a.m.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Council for Human Genome Research.
Date: September 13–14, 2021.
Open: September 13, 2021, 10:00 a.m. to
3:00 p.m.
Agenda: Report from Institute Director and
Program Staff.
Place: National Human Genome Research
Institute, National Institutes of Health, 6700B
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Closed: September 13, 2021, 3:00 p.m. to
6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Human Genome Research
Institute, National Institutes of Health, 6700B
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Closed: September 14, 2021, 8:30 a.m. to
5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Human Genome Research
Institute, National Institutes of Health, 6700B
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Rudy O. Pozzatti, Ph.D.,
Scientific Review Officer, Scientific Review
Branch, National Human Genome Research
Institute, 5635 Fishers Lane, Suite 4076, MSC
9306, Rockville, MD 20852, (301) 402–0838,
pozzattr@mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Information is also available on the
Institute’s/Center’s home page: https://
www.genome.gov/council, where an agenda
and any additional information for the
meeting will be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.172, Human Genome
Research, National Institutes of Health, HHS)
Dated: August 25, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–18726 Filed 8–30–21; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
20:08 Aug 30, 2021
Jkt 253001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Bioengineering, Cellular and Circuit
Neuroscience.
Date: October 1, 2021.
Time: 9:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Jyothi Arikkath, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5215,
Bethesda, MD 20892, (301) 435–1042,
arikkathj2@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA–RM–
21–020: Cutting Edge Informatics Tools for
Illuminating the Druggable Genome (U01).
Date: October 5, 2021.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Noffisat Oki, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, 6701 Rockledge Drive,
Bethesda, MD 20892, (240) 627–3648,
noffisat.oki@nih.gov.
Name of Committee: Integrative,
Functional and Cognitive Neuroscience
Integrated Review Group; Neuroscience of
Basic Visual Processes Study Section.
Date: October 6–7, 2021.
Time: 9:00 a.m. to 7:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892, (Virtual Meeting).
Contact Person: Kirk Thompson, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5184,
PO 00000
Frm 00090
Fmt 4703
Sfmt 4703
MSC 7844, Bethesda, MD 20892, 301–435–
1242, kgt@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: August 25, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–18728 Filed 8–30–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOUSING AND
URBAN DEVELOPMENT
[Docket No. FR–6280–D–01]
Redelegation of Authority for the
Office of Field Policy and Management
Office of Field Policy and
Management, Housing and Urban
Development (HUD).
ACTION: Notice of redelegation of
authority.
AGENCY:
Through this notice, the
Assistant Deputy Secretary for Field
Policy and Management and the
Director for Field Policy and
Management redelegate certain
operational management authority to
the HUD Regional Administrators
located in Region I (Boston, MA);
Region II (New York, NY); Region III
(Philadelphia, PA); Region IV (Atlanta,
GA); Region V (Chicago, IL); Region VI
(Fort Worth, TX); Region VII (Kansas
City, KS); Region VIII (Denver, CO);
Region IX (San Francisco, CA); and
Region X (Seattle, WA).
DATES: Applicable Date: August 25,
2021.
FOR FURTHER INFORMATION CONTACT: John
B. Shumway, Assistant General
Counsel, Administrative Law Division,
Department of Housing and Urban
Development, at 451 7th Street SW,
Room 9262; Washington, DC 20410–
0500 or telephone number 202–402–
5190 (this is not a toll-free number).
Persons with hearing or speech
impairments may access this number
through TTY by calling the Federal
Relay Service at 800–877–8339 (this is
a toll-free number).
SUPPLEMENTARY INFORMATION: In October
2020, the Secretary of HUD delegated to
the Assistant Deputy Secretary for Field
Policy and Management and the
Director for Field Policy and
Management authority for the
management and oversight of the
Department’s field operations, which
was published in the Federal Register at
SUMMARY:
E:\FR\FM\31AUN1.SGM
31AUN1
]]>Agencies
[Federal Register Volume 86, Number 166 (Tuesday, August 31, 2021)]
[Notices]
[Pages 48747-48748]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-18726]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Human Genome Research Institute; Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the National Advisory
Council for Human Genome Research.
The meeting will be open to the public as indicated below, the 94th
meeting of the National Advisory Council for Human Genome Research open
session will be livestreamed and available for viewing to the public
from https://www.genome.gov/event-calendar/94th-Meeting-of-National-
Advisory-Council-for-Human-Genome-
[[Page 48748]]
Research. The open session will be on September 13th and the start time
will be 10:00 a.m.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory Council for Human Genome
Research.
Date: September 13-14, 2021.
Open: September 13, 2021, 10:00 a.m. to 3:00 p.m.
Agenda: Report from Institute Director and Program Staff.
Place: National Human Genome Research Institute, National
Institutes of Health, 6700B Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Closed: September 13, 2021, 3:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Human Genome Research Institute, National
Institutes of Health, 6700B Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Closed: September 14, 2021, 8:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Human Genome Research Institute, National
Institutes of Health, 6700B Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Rudy O. Pozzatti, Ph.D., Scientific Review
Officer, Scientific Review Branch, National Human Genome Research
Institute, 5635 Fishers Lane, Suite 4076, MSC 9306, Rockville, MD
20852, (301) 402-0838, [email protected].
This notice is being published less than 15 days prior to the
meeting due to the timing limitations imposed by the review and
funding cycle.
Information is also available on the Institute's/Center's home
page: https://www.genome.gov/council, where an agenda and any
additional information for the meeting will be posted when
available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human
Genome Research, National Institutes of Health, HHS)
Dated: August 25, 2021.
David W. Freeman,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-18726 Filed 8-30-21; 8:45 am]
BILLING CODE 4140-01-P
